Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
AIDS (London, England)
|
November 23, 2000
Cost effectiveness of expanded antenatal HIV testing in London
M J Postma, E J Beck, C A Hankins, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 29, 2000
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]
M J Postma, A Bakker, R Welte, et al.
Pathogens and Global Health
|
December 14, 2016
Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women
G I J G Rours, Tamar Anne Smith-Norowitz, Jared Ditkowsky, et al.
AIDS Care
|
May 2, 2008
The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life
G A A Hubben, D Bishai, P Pechlivanoglou, et al.
ISBT Science Series
|
October 20, 2015
Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country
J P Pitman, R Wilkinson, S V Basavaraju, et al.
Journal De Pharmacie De Belgique
|
September 18, 2014
[Optimizing pharmacotherapy in patients with COPD by community-pharmacists: a cost-effectiveness analysis]
J F M van Boven, E Tommelein, K Boussery, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 18, 2002
[Treatment with infliximab in patients with Crohn disease; experience in 132 patients]
S R J G Smits, J A Heijman, H M van Dullemen, et al.
Vaccine
|
October 6, 2009
Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
E A M Zijtregtop, J Wilschut, N Koelma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS)
M Schlander, S Garattini, S Holm, et al.
Vaccine
|
December 17, 2008
Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination
M D M Assink, J P Kiewiet, M H Rozenbaum, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
AIDS (London, England)
|
November 23, 2000
Cost effectiveness of expanded antenatal HIV testing in London
M J Postma, E J Beck, C A Hankins, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
December 29, 2000
[Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more]
M J Postma, A Bakker, R Welte, et al.
Pathogens and Global Health
|
December 14, 2016
Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women
G I J G Rours, Tamar Anne Smith-Norowitz, Jared Ditkowsky, et al.
AIDS Care
|
May 2, 2008
The societal burden of HIV/AIDS in Northern Italy: an analysis of costs and quality of life
G A A Hubben, D Bishai, P Pechlivanoglou, et al.
ISBT Science Series
|
October 20, 2015
Investments in blood safety improve the availability of blood to underserved areas in a sub-Saharan African country
J P Pitman, R Wilkinson, S V Basavaraju, et al.
Journal De Pharmacie De Belgique
|
September 18, 2014
[Optimizing pharmacotherapy in patients with COPD by community-pharmacists: a cost-effectiveness analysis]
J F M van Boven, E Tommelein, K Boussery, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
October 18, 2002
[Treatment with infliximab in patients with Crohn disease; experience in 132 patients]
S R J G Smits, J A Heijman, H M van Dullemen, et al.
Vaccine
|
October 6, 2009
Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
E A M Zijtregtop, J Wilschut, N Koelma, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 21, 2016
The Evaluation of Economic Methods to Assess the Social Value of Medical Interventions for Ultra-Rare Disorders (URDS)
M Schlander, S Garattini, S Holm, et al.
Vaccine
|
December 17, 2008
Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination
M D M Assink, J P Kiewiet, M H Rozenbaum, et al.
Page
of 14